NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-219-2018-0-US-01 A Fully Automated System For Quantitative Myocardial Perfusion Pixel Mapping And Machine Diagnosis To Detect Ischemic Heart Disease With First-pass Perfusion Cardiac Magnetic Resonance Imaging US 62/672,787 Abandoned
NCI E-106-2017-0-PCT-02 ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS PCT PCT PCT/US2018/033236 Expired
NCI E-099-2014-0-US-09 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND METHODS OF MAKING THEM US CON 15/981,142 10538588 Issued PDF
CC E-158-2017-0-PCT-02 SYSTEMS, METHODS, AND DEVICES FOR ASSISTING OR PERFORMING
GUIDED INTERVENTIONAL PROCEDURES USING INERTIAL MEASUREMENT
UNITS AND MAGNETOMETER SENSORS 		PCT PCT PCT/US2018/033025 Expired
NCI E-017-2017-0-CN-05 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES CN National Stage 201880032676.5 Issued
NCI E-017-2017-0-EP-06 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES EP National Stage 18733012.1 Abandoned
NCI E-017-2017-0-CA-04 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES CA National Stage 3062433 Pending
NCATS E-114-2018-0-US-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS US 62/671,964 Abandoned
NCI E-017-2017-0-PCT-02 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES PCT PCT PCT/US2018/032809 Expired
NCI E-001-2016-0-KR-13 Anti-CD30 Chimeric Antigen Receptors KR National Stage 2018-7013573 Abandoned
NIDCR E-485-2013-2-US-02 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS US ORD 15/979,105 Abandoned
NCI E-010-2016-2-JP-07 Anti-BCMA Polypeptides and Proteins JP National Stage 2018-544769 Issued
NCI E-186-2015-0-US-02 PEPTIDE AND PEPTIDE MIMETIC BINDING ANTAGONISTS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE US ORD 15/977,768 10905769 Issued PDF
NCI E-010-2016-2-EP-05 Anti-BCMA Polypeptides and Proteins EP National Stage 16798612.4 Abandoned
NCATS E-095-2018-0-US-01 QUINOLINE COMPOUNDS AND THEIR PREPARATION AND USE AS ANTIMALARIAL AGENTS US 62/670,351 Abandoned
NCI E-010-2016-2-CN-04 Anti-BCMA Polypeptides and Proteins CN National Stage 201680065438.5 Issued
NIAID E-051-2012-3-CN-10 Neutralizing Antibodies To HIV-1 and Their Use CN DIV 201810445511.2 Issued
NCI E-139-2015-0-US-04 FIXATIVES AND METHODS OF USE US National Stage 15/774,480 11313772 Issued PDF
NCI E-065-2017-0-PCT-02 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY PCT PCT PCT/US2018/031618 Expired
NCI E-065-2017-0-EP-05 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY EP National Stage 18727536.7 Abandoned
NCI E-285-2016-2-JP-05 Glypican 2 As A Cancer Marker And Therapeutic Target JP National Stage 2018-543286 Pending
NCI E-065-2017-0-AU-03 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY AU National Stage 2018268970 Pending
NCI E-127-2017-0-PCT-02 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies PCT PCT PCT/US2018/031501 Expired
NCI E-127-2017-0-CA-04 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies CA National Stage 3063087 Pending
NCI E-065-2017-0-CA-04 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY CA National Stage 3059472 Pending
NCI E-075-2018-0-US-01 TETRAHEDRAL RNA SCAFFOLD FOR BIOLOGICAL APPLICATIONS US 62/668,653 Abandoned
NIDCR E-485-2013-2-US-01 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS US 62/667,843 Abandoned
NIAID E-067-2016-3-US-03 METHOD OF VACCINATION WITH AN ATTENUATED RSV VACCINE FORMULATION US National Stage 15/773,653 12102671 Issued PDF
NCI E-291-2012-0-RU-13 M971 Chimeric Antigen Receptors RU DIV 2018116582 Issued
NICHD E-210-2021-0-US-03 Kits And Methods For Predictions And Treatment Of Preeclampsia US National Stage 15/773,978 11243213 Issued PDF
NICHD E-209-2021-0-US-02 Kits And Methods To Distinguish False Labor And True Labor US National Stage 15/773,980 11204354 Issued PDF
NCI E-069-2017-0-EP-04 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL EP National Stage 18727506.0 Issued
NCI E-069-2017-0-CH-05 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL CH EP 18727506.0 Issued
NCI E-069-2017-0-GB-08 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL GB EP 18727506.0 Issued
NCI E-069-2017-0-DE-06 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL DE EP 18727506.0 Issued
NCI E-069-2017-0-FR-07 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL FR EP 18727506.0 Issued
NCI E-010-2016-2-US-09 ANTI-BCMA POLYPEPTIDES AND PROTEINS US National Stage 15/773,687 10925969 Issued PDF
NIDCR E-485-2013-0-US-04 METHODS OF TREATING OR PREVENTING PRURITIS BY BLOCKING NATRIURETIC POLYPEPTIDE
B 		US DIV 15/971,671 10583173 Issued PDF
NCI E-069-2017-0-PCT-02 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL PCT PCT PCT/US2018/031201 Expired
NCI E-285-2016-2-US-06 Glypican 2 As A Cancer Marker And Therapeutic Target US National Stage 15/773,256 11814440 Issued PDF
NCI E-055-2017-0-US-05 Combing D2C7 Immunotoxin With Check Points Inhibitors US National Stage 15/773,418 11065332 Issued PDF
NCI E-188-2010-1-US-04 Human Monoclonal Antibody Against Human Folate Receptor Beta US CON 15/970,352 Abandoned
NCI E-123-2018-0-US-01 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF US 62/666,471 Abandoned
NCI E-010-2016-2-AU-02 Anti-BCMA Polypeptides and Proteins AU National Stage 2016353067 Issued
NCI E-257-2009-1-US-23 USE OF IL-15 TO INCREASE THYMIC OUTPUT AND TO TREAT LYMPHOPENIA US DIV 15/969,647 10894816 Issued PDF
NCI E-291-2012-0-JP-14 M971 Chimeric Antigen Receptors JP DIV 2018-088908 Issued
NEI E-251-2012-3-US-16 METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) US CON 15/969,686 10480031 Issued PDF
NIAID E-079-2018-0-US-01 Antibodies and Methods for the Diagnosis, Prevention, and Treatment of Epstein Barr Virus Infection US 62/665,977 Abandoned
NCI E-098-2018-0-US-01 T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR US 62/665,234 Abandoned
NIAID E-133-2015-0-IN-06 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE IN National Stage 201837016184 Issued